Administrationof ANP carrying piceatannol, a Syk inhibitor, mitigatedpulmonary edema in ALI and dramatically improved survival in polymicrobialsepsis, but, critically, it did not increase the host’s bacterialburden. This evidence concerns the gene SYK and acute respiratory distress syndrome.